To approximate in vitro tissue culture cells to in vivo condition after sunitinib treatment, which results in a hypoxic tumor microenvironment, we attempted a comparison of the molecular changes of RCC cells under hypoxia versus normoxia conditions with a focus on TR4 protein. The gene discussed is NR2C2; the disease is renal cell carcinoma.